3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years

• The stocks listed beneath output betwixt 2.7% and 3.5%.

• They are successful antithetic sectors of the system and tin assistance diversify your portfolio portion besides generating plentifulness of recurring currency flow.

• 10 stocks we similar amended than AbbVie ›

Want immoderate prime income-generating investments you tin enactment successful your portfolio for the agelong term, and not interest about? The stocks listed beneath cheque disconnected those boxes and tin marque for perfect investments to bargain and hold. Not lone bash they connection precocious yields today, but they've besides been increasing their payouts for decades.

AbbVie (NYSE: ABBV), Home Depot (NYSE: HD), and ExxonMobil (NYSE: XOM) tin diversify your portfolio portion besides mounting you up to make plentifulness of recurring currency travel for the agelong term. Here's a person look astatine them, and wherefore they're among the champion dividend stocks you tin bargain today.

Pharma banal AbbVie pays investors a output of astir 2.9% close now, which is much than treble the S&P 500 mean of 1.2%. The institution spun disconnected from Abbott Laboratories back successful 2013, and erstwhile including its streak arsenic portion of that business, it spans much than 50 consecutive years, which means AbbVie is simply a Dividend King.

The company's astir caller summation is simply a 5.5% boost to its payout successful airy of its beardown fiscal results. Since splitting disconnected from Abbott Labs, AbbVie has accrued its quarterly dividend payments by implicit 330%. AbbVie hasn't simply been boosting the dividend to support its streak going; it has been making meaningful complaint hikes for its shareholders.

Through the archetypal 9 months of the year, the institution has demonstrated beardown maturation with income rising by 8%, to $44.5 billion. Humira is nary longer its top-selling drug, but AbbVie has been capable to pivot to different drugs, with Skyrizi and Rinvoq generating a combined $18.5 cardinal done the archetypal 3 quarters, good supra Humira's existent quarterly tally of $3.3 billion.

With a divers premix of drugs treating assorted diseases and conditions, AbbVie is 1 of the astir robust and safest dividend stocks you tin find successful the healthcare sector.

Home betterment elephantine Home Depot is different apical dividend maturation banal to bargain and hold. While it whitethorn not person the awesome maturation streak that AbbVie has going, it has been raising its dividend for 16 consecutive years. And since 2020, its quarterly dividend has grown by much than 50%.

It's presently yielding 2.7%, which is simply a coagulated complaint for the retailer. The concern is facing challenges arsenic discretionary spending has been down amid challenging economical conditions. But what's encouraging is that the institution inactive expects income maturation of 3% for its existent fiscal twelvemonth (it ends successful January).